
Regenerative Medicine and Dentistry (RMD) is announcing a Call for Papers for the topic “ Stem Cell Engineering, Organoids, and Cell-Free Therapies ”. Stem cell engineering, organoid technology, and cell-free therapeutic strategies are collectively redefining the boundaries of regenerative medicine. Stem cell-derived constructs now offer unprecedented control over cellular identity and tissue fate, while organoids recapitulate the multicellular complexity of human organs with remarkable fidelity. In parallel, cell-free approaches, encompassing extracellular vesicles, exosomes, secretome-based interventions, and acellular biomaterials, are emerging as potent, scalable alternatives that circumvent the translational barriers associated with live-cell therapies. To capture the extraordinary momentum across these converging fields, our journal is pleased to announce a Call for Papers on Stem Cell Engineering, Organoids, and Cell-Free Therapies. This Call for Papers seeks to consolidate the most rigorous, high-impact research at the intersection of stem cell biology, three-dimensional tissue modeling, and cell-free regenerative strategies. The journal aspires to build a definitive reference collection that bridges fundamental discovery with clinical application, offering a platform where developmental biologists, bioengineers, and translational scientists can share transformative findings and shape the future of restorative medicine. We warmly welcome original research articles, comprehensive reviews, and forward-looking perspectives that demonstrate methodological innovation, mechanistic depth, and tangible potential for improving patient outcomes. Topics of particular interest include (but are not limited to): - Engineering strategies for directing stem cell fate and enhancing therapeutic potency; - Organoid construction with advanced vascularization, innervation, and immune integration; - Cell-free modalities including exosomes, extracellular vesicles, and secretome-based therapies; - Scalable biofabrication and bioprocessing platforms for clinical translation; - Disease modeling, drug screening, and personalized medicine applications. Academic Editor: Assoc. Prof. Long Bai Shanghai University Prof. Akon Higuchi Wenzhou Medical University Dr. Lan Xiao Griffith University Submission deadline: 31 October 2026 Office Contact: rmd@sciltp.com Instruction for Authors: https://www.sciltp.com/journals/rmd/instructionForAuthors Submission Link: https://sciflux.org/authors/submissions All manuscripts will undergo peer review in accordance with the journal’s established policies and procedures. Final acceptance will be based on the peer-review reports and the evaluation of the Academic Editors and the Editor-in-Chief. Decisions will be made by the Editor-in-Chief or Academic Editors who have no conflicts of interest with any of the authors.

Introduction: Regenerative Medicine and Dentistry (RMD) is announcing a Call for Papers for the topic “ Clinical Cases in Regenerative Medicine and Dentistry ”. This Call for Papers aims to highlight innovative clinical applications, evidence-based practices, and advances in regenerative therapies for dental and medical applications We sincerely invite you to contribute your work in the form of original research articles, case reports, review articles, and perspective papers. Topics of Interest Include (but are not limited to): Regenerative Endodontics: Procedures for immature and mature teeth, including management of apical periodontitis, trauma-induced resorption, and apexification alternatives Periodontal and Alveolar Regeneration: Techniques addressing intrabody defects, fureation involvement, and tooth loss using growth factors or cell-based therapies Cell-Based Therapies in Practice: Cases utilizing dental pulp stem cells, apical papilla cells, or mesenchymal stem cells for pulp revitalization, periodontal, and tissue regeneration Digital workflows in Regeneration: Use of 3D printing, CAD/CAM, and AI-driven planning for precision tissue engineering Clinical Applications of Biomaterials and Biologics: Clinical applications of scaffolds and gene-activated materials enhancing tissue integration and healing Complex Case Management: Multi-disciplinary approaches to trauma, congenital defects, and oncological reconstruction Long-Term Outcomes and Complications: Follow-up studies on survival rates, histological validation, and management of failures Please refer to the Instructions for Authors for formatting and submission details. We warmly invite colleagues to submit manuscripts relevant to these themes to share their latest research findings and insights. Article Processing Charges (APCs) are waived before the submission deadline. Academic Editor: Assoc. Prof. Yuelian Liu (Maria) Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), VU University and University of Amsterdam, the Netherlands. Submission deadline: 3 September 2026 Instruction for Authors: https://www.sciltp.com/journals/rmd/instructionForAuthors Submission Link: https://sciflux.org/authors/submissions Contact:  RMD Editorial Office (rmd@sciltp.com) All manuscripts will undergo peer review in accordance with the journal’s established policies and procedures. Final acceptance will be based on the peer-review reports and the evaluation of the Academic Editors and the Editor-in-Chief. Decisions will be made by the Editor-in-Chief or Academic Editors who have no conflicts of interest with any of the authors.